stockrow
Friday 6 November 2026
Export NRC’s income statement to Excel — free account
National Research Corporation
NRC Healthcare Health Information Services
National Research Corporation’s revenue for fiscal 2025 (year ended December 2025) was $137.4 million, down 3.96% from fiscal 2024.
- Revenue
- +11.0%
- EPS
- +20.3%
- Free cash flow
- −31.4%
- Total debt
- +29.1%
Quarter to September 2026, against a year earlier
25.83
0.35
+1.37%
Follow NRC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 5 | 5 | 6 |
+8 more TTM periods Free account |
| 236.21% | 39.82% | 40.43% | 49.88% | ||
| 4.46% | 4.00% | 6.47% | 8.45% | ||
ROIC |
11.64% | 10.32% | 14.39% | 16.64% | |
Return on Tangible Assets |
26.42% | 20.34% | 40.00% | 46.93% | |
Average Days of Receivables |
46.36 | 35.59 | 29.79 | 30.91 | |
Free Cash Flow per Share |
0.85 | 0.98 | 0.80 | 0.70 | |
Free Cash Flow |
18.45 | 21.64 | 17.43 | 15.74 | |
Capital Expenditures |
(5.32) | (7.87) | (9.55) | (10.71) | |
| Other line items | |||||
Cash ROIC |
19.91% | 22.57% | 19.35% | 16.90% | |
Accounts Receivable Turnover |
9.27 | 10.56 | 12.17 | 12.04 | |
Accounts Payable Turnover |
45.04 | 42.74 | 24.88 | 44.33 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
9.14 | 9.04 | 15.35 | 8.15 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.39) | (0.38) | (0.38) | (0.35) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
43.71% | 45.06% | 41.74% | 39.89% | |
Share Based Compensation of Revenue |
7.48% | 8.44% | 3.43% | 2.41% | |
Interest Coverage |
2.90 | 2.73 | 3.82 | 4.74 | |
Operating CF/Net income |
3.88 | 5.32 | 3.09 | 2.34 | |
Depreciation/Fixed assets |
0.22 | 0.22 | 0.21 | 0.19 | |
Capex/Depreciation |
(0.62) | (0.90) | (1.14) | (1.39) | |
Revenue per Share |
6.62 | 6.36 | 6.36 | 6.14 | |
Operating CF per Share |
1.09 | 1.34 | 1.24 | 1.18 | |
Capex per Share |
(0.24) | (0.36) | (0.44) | (0.48) | |
Capex to Sales |
0.04 | 0.06 | 0.07 | 0.08 |
Columns are period end dates · fundamentals updated 6 Nov 2026